Delivery Order SPE2DB22D3004-SPE2DB25FSD91
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,625.67 to AmerisourceBergen Drug Corp for ZORYVE 0.15% Cream 60GM, a pharmaceutical product. This contract was competitively awarded with no set-aside designation under a firm fixed-price arrangement, with an ultimate completion date of August 4, 2025. The place of performance is listed as Conshohocken, PA 19428, which aligns with AmerisourceBergen's corporate headquarters location. This delivery order operates as a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for ZORYVE 0.15% Cream in a 60-gram size. This firm fixed-price delivery order, valued at $1,018.11, represents a competitive award with no set-aside designation and carries an ultimate completion date of July 29, 2025. The contract is executed under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Cream 60GM with a ceiling value of $7,270.70. This contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing, with a delivery deadline of July 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This delivery order, valued at $1,329.20, was awarded on August 19, 2025, to AmerisourceBergen Drug Corp for the supply of ZORYVE 0.3% Cream in 60-gram quantities. The contract was funded by the Defense Logistics Agency (DLA), the Department of Defense's supply and logistics organization, and represents a firm fixed-price delivery order with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is...
- The Defense Logistics Agency awarded a delivery order valued at $1,849.81 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Cream 60GM, a pharmaceutical product for federal medical procurement. The contract utilized firm fixed pricing with no set-aside designation, indicating competitive award through open competition. The award was issued on August 19, 2025, with an ultimate completion date of August 20, 2025. Performance of this delivery order takes place at AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,582.11 by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of ZORYVE 0.15% Cream in 60-gram quantities. This is a firm fixed-price contract with an ultimate completion date of August 1, 2025, and no set-aside designation was used in the award. The contract will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $2,749.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Cream in 60GM quantity on August 12, 2025, with completion targeted for August 13, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned to fulfill...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZORYVE 0.3% Cream, a pharmaceutical product, with a ceiling value of $8,709.68 and a performance period through May 9, 2025. The contract is a firm-fixed-price type and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication ZORYVE 0.3% cream. The contract has a firm fixed price, a ceiling value of $2,378.05, and a period of performance through May 2, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Zoryve 0.3% cream in 60 gram packages, with a firm fixed price of $2,186.85 and a completion date of June 25, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSD91Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,457.92 to AmerisourceBergen Drug Corp for ZORYVE 0.15% Cream (60 grams) on August 25, 2025, with completion expected by August 26, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major healthcare solutions provider and pharmaceutical distributor serving federal medical procurement needs. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (designation SPE2DX), which extends through December 2026 and enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in fulfilling competitive pharmaceutical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order for ZORYVE represents the company's ongoing role as a critical vendor within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/25/25 |